Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Salivary gland-type renal carcinoma, a subset of collecting duct carcinoma: case report and meta-analysis of the entity.

Williams PA, Mai KT.

Histopathology. 2013 Feb;62(3):514-8. doi: 10.1111/his.12017. No abstract available.

PMID:
23339365
2.

Synchronus renal cell carcinoma and Bellini duct carcinoma: a case report on a rare coincidence.

Auguet T, Molina JC, Lorenzo A, Vila J, Sirvent JJ, Richart C.

World J Urol. 2000 Dec;18(6):449-51.

PMID:
11204268
3.

[Bellini duct carcinoma of the kidney: a case report].

Sue Y, Kunieda M, Yamaguchi S, Hashimoto H, Yachiku S.

Hinyokika Kiyo. 1997 Mar;43(3):213-6. Review. Japanese.

PMID:
9127757
4.

Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship.

Gupta R, Billis A, Shah RB, Moch H, Osunkoya AO, Jochum W, Hes O, Bacchi CE, de Castro MG, Hansel DE, Zhou M, Vankalakunti M, Salles PG, Cabrera RA, Gown AM, Amin MB.

Am J Surg Pathol. 2012 Sep;36(9):1265-78.

PMID:
22895263
5.

Vinculin: its possible use as a marker of normal collecting ducts and renal neoplasms with collecting duct system phenotype.

Kuroda N, Naruse K, Miyazaki E, Hayashi Y, Yoshikawa C, Ashida S, Moriki T, Yamasaki Y, Numoto S, Yamamoto Y, Yamasaki I, Hiroi M, Shuin T, Enzan H.

Mod Pathol. 2000 Oct;13(10):1109-14.

6.

Sarcomatoid collecting-duct carcinoma of the kidney.

Charfi S, Ayadi L, Ellouze S, Khabir A, Chtourou I, Gouiaa N, Bahri I, Sellami-Boudawara T.

Clin Genitourin Cancer. 2007 Dec;5(7):452-4. doi: 10.3816/CGC.2007.n.034.

PMID:
18272028
7.

Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney.

Osunkoya AO, Young AN, Wang W, Netto GJ, Epstein JI.

Am J Surg Pathol. 2009 Jul;33(7):1103-6. doi: 10.1097/PAS.0b013e3181a13e7b.

PMID:
19390420
8.

Collecting duct carcinoma of the kidney: a case report with variable immunohistochemistry.

Connolly RM, Downey P, McCaffrey JA.

Ir J Med Sci. 2006 Jul-Sep;175(3):66-8.

PMID:
17073252
9.

Bellini duct carcinoma: further evidence for this rare variant of renal cell carcinoma.

Rumpelt HJ, Störkel S, Moll R, Schärfe T, Thoenes W.

Histopathology. 1991 Feb;18(2):115-22.

PMID:
1707029
10.

CD151 expression can predict cancer progression in clear cell renal cell carcinoma.

Yoo SH, Lee K, Chae JY, Moon KC.

Histopathology. 2011 Jan;58(2):191-7. doi: 10.1111/j.1365-2559.2011.03752.x.

PMID:
21323946
11.

Asynchronous collecting duct carcinoma of the kidney and pulmonary adenocarcinoma. A case report.

Okoń K, Demczuk S, Dobrowolska B, Kaznowska E, Dobrowolski Z, Stachura J.

Pol J Pathol. 2002;53(4):229-34.

PMID:
12597341
12.

C-reactive protein: a clinically useful biomarker in renal cell carcinoma.

Johnson TV, DeLong J, Master VA.

JAAPA. 2012 Jan;25(1):45-7. No abstract available.

PMID:
22384756
13.

Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.

Ozolek JA, Bastacky SI, Myers EN, Hunt JL.

Laryngoscope. 2005 Jun;115(6):1097-100.

PMID:
15933529
14.

[Renal Bellini's collecting duct carcinoma: report of a case].

Wang W, Yu GH, Qu GM, Yao WD, Jiang L.

Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):631. Chinese. No abstract available.

PMID:
21092594
15.

MUC1 immunoexpression is a virtually constant feature of clear cell renal cell carcinoma metastatic to the pancreas.

Pająk J, Liszka L, Mrowiec S, Gołka D, Lampe P.

Adv Anat Pathol. 2012 Mar;19(2):125-7. doi: 10.1097/PAP.0b013e318248bd97. No abstract available.

PMID:
22313840
16.

Multifocal capillary hemangioma-like vascular proliferation of the kidney associated with clear cell renal cell carcinoma: a case report and review of the literature.

Fellegara G, Rosai J.

Int J Surg Pathol. 2013 Aug;21(4):424-6. doi: 10.1177/1066896912474340. Epub 2013 Jan 30. Review.

PMID:
23364358
17.

An unusual renal cell carcinoma, unclassified.

Perez-Montiel MD, Suster S.

Adv Anat Pathol. 2003 Sep;10(5):291-5. No abstract available.

PMID:
12973050
18.

Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma.

Tawfik OW, Kramer B, Shideler B, Danley M, Kimler BF, Holzbeierlein J.

Arch Pathol Lab Med. 2007 Feb;131(2):261-7.

PMID:
17284111
19.

Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma.

Kuroda N, Guo L, Toi M, Naruse K, Miyazaki E, Hayashi Y, Yoshikawa C, Ashida S, Shuin T, Enzan H.

Appl Immunohistochem Mol Morphol. 2001 Dec;9(4):315-8.

PMID:
11759057
20.

Renal cell carcinoma, chromophobe type, with collecting duct carcinoma and sarcomatoid components.

Gong Y, Sun X, Haines GK 3rd, Pins MR.

Arch Pathol Lab Med. 2003 Jan;127(1):e38-40.

PMID:
12562294
Items per page

Supplemental Content

Write to the Help Desk